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ABSTRACT
International Journal of Exercise Science 12(2): 355-365, 2019. This study examined the effects of
Assault™ pre-workout supplementation on peak power output (PP), mean power output (MP), and percent
decline in power output (% decline) during repeated, Wingate anaerobic tests. Thirteen healthy, physically active
participants (7 male, 6 female) completed the randomized, double-blind, placebo-controlled crossover design
with two conditions, supplement and placebo. The participants visited the laboratory for a total of three visits, 2-7
days apart. During visit 1, the participants completed a 4-minute familiarization warm-up on the Monark cycle
ergometer and performed one baseline, 30-second Wingate cycle ergometry test. During visits 2 and 3, the
participants consumed either the pre-workout supplement or placebo flavored maltodextrin (randomized by a
third party) and waited 20 minutes before beginning the test protocol. Each participant then completed a 4minute warm-up on the Monark cycle ergometer followed by four, 30-second Wingate tests, with a 5-minute rest
between each Wingate. There were no significant two-way condition x Wingate trial interactions for PP (F=0.713,
p=0.566), MP (F=0.669, p-value=0.590), or % decline (F=0.398 p=0.540). There was a significant main effect for the
Wingate trial for both PP (F=10.632, p=0.002) and MP (F=11.781, p =0.001), but there was no main effect for the
Wingate trial for % decline. There were no main effects for condition for any of the variables. The pre-workout
supplement examined in this study did not elicit ergogenic effects on anaerobic power output (PP or MP) or the
maintenance (% decline) during multiple Wingate tests.
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INTRODUCTION
Pre-workout supplementation has become very popular in recreational and competitive
athletes. Athletes ingest pre-workout supplements in an attempt to enhance focus, strength,
and power, as well as delay fatigue (24). There are many pre-workout supplements on the
market, containing several combinations of active ingredients, but caffeine is the primary
active ingredient in most pre-workout supplements. The ingestion of caffeine-containing preworkout supplements has been shown to increase performance measures when taken 20
minutes prior to a workout (30). Caffeine is suggested to promote strength and power
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performance by increasing calcium release from the sarcoplasmic reticulum leading to
increased muscle fiber contractility (26, 30). Caffeine has also been shown to delay the
perceptions of fatigue by acting as an adenosine receptor antagonist (15). Pre-workout
supplements also commonly contain amino acids, beta-alanine, creatine, citrulline-malate,
arginine, and B vitamins (B-6, B-12). These additional active ingredients are often combined
with caffeine to produce a synergistic effect on anaerobic performance. There is, however,
limited research on ergogenic effects of acute supplementation of caffeine in combination with
these other active ingredients on anaerobic performance markers, such as repeated, highintensity cycle ergometry trials.
The combination of ingredients such as caffeine, creatine, and amino acids in pre-workout
supplements has been associated with delayed fatigue and enhanced performance during
high-intensity anaerobic exercise (29). Pre-workout supplements containing multiple
ingredients such as branched-chain amino acids (BCAAs), aspartic acid, and B vitamins may
augment the effects of caffeine (5, 6, 18, 31, 34). Branched-chain amino acids, such as leucine,
have been shown to enhance cognitive function (34), increase protein synthesis, and decrease
protein degradation leading to increased muscle mass (6). Aspartic acid may improve
muscular performance by lowering the level of ammonia in the blood (4), while B vitamins, in
particular B-6 and B-12, have displayed an important role in metabolic pathways involved in
exercise and DNA synthesis, respectively (36). It is currently unknown, however, how the
combination of these ingredients may augment the effects of caffeine during short-term, high
intensity anaerobic exercise.
The effectiveness of caffeine-containing pre-workout supplements for the enhancement of
anaerobic performance remains unclear. Pre-workout supplementation has been shown to
increase the total training volume (5, 21) as well as peak and mean power performance during
a resistance training protocol (21). In addition, pre-workout supplementation resulted in
increased leg press strength, perceived energy, alertness, focus, and reaction time (30). In
contrast, pre-workout supplementation prior to a single Wingate anaerobic test was reported
to have no significant ergogenic effects on anaerobic power or performance (10,16). Similarly,
caffeine supplementation alone had no effect on anaerobic power or capacity from four
Wingate anaerobic tests (22). Thus, there are data supporting (5, 21) an ergogenic effect of
caffeine containing pre-workout supplements on anaerobic and strength parameters, but the
effectiveness of various combinations of ingredients on anaerobic power and capacity from a
Wingate test is less clear. No previous studies, however, have examined the effects of the
combination of ingredients contained in the AssaultTM pre-workout supplement on anaerobic
performance during repeated Wingate anaerobic tests. Therefore, the purpose of this study
was to examine the effects of Assault™ pre-workout supplement containing caffeine, BCAAs,
creatine, beta-alanine, arginine, vitamin B-6, and vitamin B-12 (Assault™, MusclePharm, Inc.,
Denver, CO, USA) on peak power output (PP), mean power output (MP), and percent decline
in power output (% decline) during repeated Wingate anaerobic tests. We hypothesized the
pre-workout supplement would result in an increased PP and MP, but no change or a lower %
decline for repeated Wingate tests, compared to a placebo.
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METHODS
Participants
Fourteen healthy, college-aged students, with experience in high-intensity interval training
were recruited for this study. One participant dropped out due to scheduling conflicts. Thus,
the analyses included data for thirteen participants. The sample size is based on previous
research average values of anaerobic peak power (36) using a medium-to-large effect size of
0.5-0.8, an alpha criterion of 0.05, and a power level of 0.8. The participants consisted of 7
males (25±4 years; 180.1±7.2 cm; 82.2±10.9kg), and 6 females (24±2 years; 163.3±14.0cm;
64.6±6.7kg). Participants were excluded if they consumed more than 200 mg of caffeine (the
equivalent caffeine content of 2 cups of coffee) on a regular basis, were pregnant, or had any
allergies to the ingredients listed on the supplement label. All participants were between the
ages of 18-35, involved in strength training 3-5 times a week for at least one year, and were free
from any musculoskeletal or neuromuscular injuries. The investigation was approved by the
University of Kentucky Institutional Review Board for the protection of human testing and all
participants completed a health history questionnaire and signed informed consent documents
before testing.
Protocol
This study was a randomized, double-blind, placebo-controlled crossover design with two
conditions, supplement and placebo. The participants visited the Exercise Physiology
laboratory for a total of three visits, with each visit scheduled between 2-7 days apart.
Participants were instructed to: 1) refrain from eating 2 hours prior to testing; 2) refrain from
exercise 12 hours prior to testing; 3) maintain their normal exercise habits and avoid any
unaccustomed exercise bouts during their enrollment in the study; and 4) refrain from caffeine
24 hours prior to testing. During visit 1, the participants provided informed consent,
completed pre-exercise testing health questionnaires and personal information forms, and
performed one baseline 30-second Wingate cycle test. After the Wingate test, the participants
were provided a 24-hour food log to complete prior to visits 2 and 3. During visits 2 and 3, the
participants consumed either the pre-workout supplement or placebo (randomized by a third
party) and waited 20 minutes before beginning the test. Each participant then completed a 4minute warm-up on the Monark cycle ergometer followed by four 30-second Wingate tests
with a 5-minute rest between each Wingate.
Baseline Measurements: During the first visit, the body weight, heart rate, and blood pressure
were measured, followed by a baseline Wingate test on a Monark Cycle Ergometer (Monark,
model 894E). Prior to the test, the seat height was adjusted so that the participants’ legs were
near full extension at the bottom of the pedal revolution. Toe cages were used to maintain
pedal contact throughout the test. A warm-up was then performed, which consisted of 4minutes of cycling against 0 kg resistance, with two 5-second sprint intervals at the end of the
2nd and 3rd minutes of the warm-up. The sprints were preformed using 7.5% of the
participant’s body weight as resistance. A 1-mintute passive rest followed the warm-up. The
Wingate test began with unloaded cycling where the pedaling cadence was increased as high
as possible. The resistance (7.5% of the participant’s body weight) was automatically applied
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when the cadence exceeded 110 rev⋅min-1 and the participants were instructed to maintain the
cadence as high as possible for 30-seconds. The PP was measured as the highest 5-second
average power and the MP was measured as the average power during the 30-second test (3).
The minimum power was measured as the lowest 5-second power and was use to calculate the
percent decline in power output (%decline) using the following equation (3): (peak power –
minimum power/ peak power) x 100.
Food log: The participants were instructed to record all food and beverages consumed 24hours prior to the experimental testing sessions (visits 2 and 3). The participants were asked to
consume a similar diet prior to visits 2 and 3. The total energy and macronutrient intake (kcals)
were quantified (www.supertracker.usda.gov) for further analysis to determine if there were
any differences between visits 2 and 3.
Table 1. AssaultTM Pre-workout supplement ingredients
Ingredients
Calories
Total Carbohydrates
Sugars
Vitamin C
Vitamin E
Niacin
Vitamin B6
Vitamin B12
Calcium
Sodium
Potassium
ATP Amplifier Blend
Carnosyn Patented Beta Alanine (2,000 mg), L-Tyrosine, L-Aspartic Acid, Red Beet
Extract High in Nitrates, (DMG) Dimethylglycine HCI
Cellular Transport & Insulin Activator
Dextrose, L-Glycine, Ribose, Cinnulin PF (Cinnamomum Burmannii) Bark Extract
Athlete Performance Blend
Creatine Nitrate, L-Arginine Nitrate,
BCAA Nitrate 3:1:2 Ratio (L-Leucine, L-Valine, L-Isoleucine)
Energy and Neuro Igniter
Choline Bitartrate, Glucuronolactone, PureEnergy Matrix (Caffeine Anhydrous,
Pterostilbene), Huperzine A
Hydration System
Taurine, Coconut Water Powder ,L-Glutamine

Amount per serving
10
2g
2g
500 mg
200 IU
25 mg
15 mg
90 mcg
171 mg
50 mg
40 mg
3,500 mg
2,952 mg
2,000 mg
1,750 mg
1,200 mg

Experimental Trials: Visits 2 and 3 were identical, other than the beverage that was consumed.
Upon entering the lab, resting blood pressure and heart rate were measured and a 24-hour
food log was collected from each participant. Next, participants consumed either a preworkout supplement (Table 1) or placebo beverage (randomized by a third party). Participants
were given the supplement per label instruction, which resulted in a caffeine dose of 4.2 ± 0.69
mg·kg-1. The placebo was flavored maltodextrin. The participants waited 20 minutes before
performing the same 4-minute warm-up as the baseline trials. Following the warm-up, the
participants rested for 1 minute. Next, the participants began the first of four, 30-second
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Wingate tests with 5-minute rests in between. The Wingate tests followed the same procedures
as the baseline trial. During the 5-minute rest, the participants were instructed to stay on the
bike for the first minute and get back on the bike for the last minute to help reduce instances of
nausea or fainting due to high intensity interval exercise. The other 3 minutes they were free to
rest on or off the bike at their preference and drink water ad libitum. After completing the
fourth Wingate tests, the participants were instructed to complete a 5 minute cool down at
their own pace against 0 kg of resistance.
Statistical Analysis
The reliability of the Wingate test was assessed with intraclass correlation coefficient (ICC) and
standard error of the measurement (SEM) for the baseline trial and 1st Wingate of the placebo
condition. The peak power, mean power, and % decline values for each test were examined
using separate, two-way (2 conditions (SUP and PL) x 4 Wingate trials) repeated measures
ANOVAs. Follow up analyses included one-way repeated measures ANOVAs and paired
samples t-test. In addition, paired samples t-tests were used to determine if there were
differences in total and macronutrient energy intake (kcals) between visit 2 and visit 3. An
alpha level of p<0.05 was considered statistically significant for all comparisons. All statistical
analyses were performed with Statistical Package for the Social Sciences software (SPSS
version 24).
RESULTS
The ICC values (SEM) for the peak power, mean power, and % decline were R=0.981 (38.4 W),
R=0.980 (23.4 W), and R=0.893 (3.1 W), respectively. There was no significant two-way condition x
Wingate trial interaction (F=0.148, p=0.928) and no main effect for condition (F=0.160, p=0.697) for
peak power (Table 2). There was, however, a main effect (F=10.632, p=0.002) for the Wingate trial
for peak power. The follow-up pairwise comparisons (collapsed across condition) indicated the
peak power from trial 1 (909.3±81.3) was significantly greater than trial 2 (826.7±73.6), 3
(743.5±57.80) and 4 (720.3±56.8). In addition, trial 2 mean power was greater than 3 and 4, but 3
and 4 were not different (Figure 2).
Table 2. Mean±SD results for four Wingate Trials within each condition, placebo (PL) and supplement (SUP), for
peak power (PP), mean power (MP), and percent decline (%decline). Main effects for the within trial findings are
presented in text.

PP
Trial 1

PL
904.4±280.9

SUP
914.2±308.7

PL
603.9±168.4

SUP
614.0±174.4

% Decline
PL
SUP
57.1±8.8
55.8±8.5

Trial 2

825.2±264.6

828.2±269.5

540.6±144.3

546.9±149.0

58.5±12.5

58.8±10.6

Trial 3

746.5±207.2

740.5±218.2

500.6±110.3

494.6±125.2

61.1±13.7

59.1±11.8

Trial 4

714.1±197.0

726.5±218.7

485.0±117.1

491.7±129.7

60.8±11.8

61.0±11.3
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Figure 2. Peak power comparisons between conditions (Placebo and Supplement) for each Wingate trial. A:
Displays no difference (no interaction effect) in anaerobic peak power for condition across all Wingate trails. B:
Displays the mean comparisons for peak power for each Wingate trial (main effect for trial). *Lower than Trial 1
p<0.05, #Lower than Trial 2 p<0.05

There was no significant two-way condition x Wingate trial interaction (F=0.669, p-value=0.590)
and no main effect for condition (F=0.678, p-value=0.426) for mean power. There was, however, a
main effect (F=11.781, p =0.001) for the Wingate trial for mean power (Table 2). The follow-up
pairwise comparisons (collapsed across condition) indicated the mean power from trial 1
(609.0±47.4) was significantly greater than trial 2 (543.7±40.5), 3 (497.6±32.4) and 4 (488.4±33.9). In
addition, trial 2 mean power was greater than 3 and 4, but 3 and 4 were not different (Figure 3).
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Figure 3. Mean power comparisons between conditions (Placebo and Supplement) for each Wingate trial. A:
Displays no differences (no interaction effect) in anaerobic mean power for condition across all Wingate trials. B:
Displays the mean comparisons for mean power for each Wingate trial (main effect for trial). *Lower than Trial 1
p<0.05, #Lower than Trial 2 p<0.05

There was no significant two-way condition x Wingate trial interaction (F=0.713, p=0.566) and no
main effect for condition (F=0.398 p=0.540) or Wingate trial (F=1.791, p=0.212) for %decline (Table
2; Figure 4).
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Dietary food intake comparing visit 2 and 3 resulted in no significant difference in total kCals
(p=0.226), PRO (p=0.352), CHO (p=0.794), or FAT (p=0.864).

DISCUSSION
This study examined the effects of the commercially available pre-workout supplement
AssaultTM on anaerobic power (MP and PP) and maintenance of power (% decline) using
repeated 30 second Wingate tests. The results of the current study indicated supplementation
with the pre-workout AssaultTM had no effect on MP, PP, or %decline. Currently, there is
conflicting evidence regarding the effectiveness of pre-workout and/or caffeine
supplementation to improve short-duration, high intensity anaerobic power output (9, 10, 13,
17, 19, 21, 22, 23, 27, 35, 36). For example, previous studies showed no effect of ~1-2mg·kg-1 of
caffeine supplementation alone on anaerobic power from a cycle ergometry sprint test in
untrained, moderately active males and females (17) or on anaerobic power during a 25-s
treadmill sprint test in untrained, recreationally active males (23). Furthermore, a caffeine dose
of ~6mg·kg-1 was reported to have no effect on the anaerobic power output from repeated
Wingate tests in untrained, moderately active males (22). In contrast, multi-ingredient preworkout supplementation, containing a relative does of 3.6 mg·kg-1 caffeine resulted in
increased peak and mean anaerobic cycling power output during a single 20-s maximal effort
test in trained males (27) and caffeine supplementation (5 mg·kg-1) alone improved Wingate
peak power in trained male athletes (35). Thus, there is conflicting evidence regarding the
effectiveness of caffeine and caffeine containing supplements to improve anaerobic
performance. In contrast to previous evidence (27, 35) indicating an ergogenic effect of caffeine
containing pre-workout supplementation and caffeine supplementation alone, the current
findings supported those of others (17, 22, 23) and indicated no changes in anaerobic
performance parameters after supplementation.
It has been suggested that caffeine may improve anaerobic performance through several
mechanisms including, increased motor unit firing, calcium ion mobilization from the
sarcoplasmic reticulum, and increased nitric oxide (NO) concentration in skeletal muscle (27,
36). These effects, however, may be dependent upon the relative caffeine dosage, subject
training level, and muscle fiber type characteristics (17, 22, 23). Specifically, it has been
suggested that doses of 4-6mg·kg-1 may be necessary to facilitate increased anaerobic and
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strength measurements in trained athletes (20). Studies have found highly trained athletes
demonstrated an increase in anaerobic performance when consuming 4-6mg·kg-1 doses of
caffeine (19, 35, 36), whereas untrained or non-specifically trained (i.e., not competitive
cyclists) individuals demonstrated no improvement in anaerobic performance after similar
caffeine doses (11, 13, 22). It is possible the lack of ergogenic effect of the pre-workout
examined in this study is due to the low relative caffeine dosage (4.2 ± 0.69mg·kg-1; range =
3.1-5.6 mg·kg-1) for physically active, but non-specifically trained participants (i.e., not
competitive cyclists) (17, 22, 23). Previous studies (1, 28, 33) have also suggested the muscle
fiber type contributions during exercise may be important determinates in the effectiveness of
caffeine supplementation. High intensity anaerobic exercise such as Wingate cycle tests, rely
heavily on anaerobic energy production through the phosphocreatine (PCr) and glycolytic
pathways, which are more developed in fast-twitch glycolytic fibers (FG) (22). Caffeine acts in
the central nervous system as an adenosine receptor antagonist (1) and may delay the onset of
fatigue during exercise (14). Adenosine receptors are found in greater concentrations in slow
oxidative than FG fiber types (1). Therefore, caffeine may not be as effective for improving
high intensity cycle ergometry performance, compared with longer duration, aerobic based
exercise, due to the reliance on anaerobic energy systems and FG fibers.
The primary active ingredient in this pre-workout supplement was caffeine (30). There were,
however, a number of other ingredients (e.g., red beet extract, dimethylglycine HCL, amino
acids, L-tyrosine, leucine, and huperzine) that have been reported to have acute effects on
exercise performance. For example, red beet extract has been shown to improve vascular
control and increase skeletal muscle blood flow during exercise, therefore improving
intramuscular pH and resynthesizing creatine phosphate (PCr) (16). There is evidence that
dimethylglycine HCL enhances mitochondrial efficiency through vasodilation and increased
blood flow to skeletal muscles (27). Previous studies, however, have not demonstrated
ergogenic effects on anaerobic power output for red beet extract (8) or dimethylglycine HCL
(2) supplementation alone. Other active ingredients such as amino acids, L-tyrosine, leucine,
and huperzine A are known to improve cognitive function and slow the onset of fatigue in
anaerobic exercise (12, 25, 37). It is believed that these ingredients act synergistically to
enhance performance in anaerobic strength and power output (5). The results of this study,
however, showed no significant difference between the supplement and placebo conditions in
% decline (power maintenance) after consecutive Wingate trials.
The pre-workout supplement examined in this study also contained ingredients that have
potential effects on anaerobic energy metabolism after long-term dosing strategies (>4 weeks).
For example, beta-alanine and creatine are active ingredients in the pre-workout supplement
that independently elicit positive long-term effects on high intensity anaerobic power (27).
Beta-alanine has been shown to increase strength and power due to increased carnosine levels
and intramuscular buffering capacity after ~4 weeks of supplementation (32). The
recommended dose of beta-alanine to elicit increased carnosine levels is 3-6 g·day-1 for 2 to 4
weeks (31). Supplementation with creatine results in increased phosphocreatine stores for
high-intensity activities after 1 to 4 week dosing strategies (7, 32). The recommended dose for
creatine to elicit effects is 5 g·day-1 for 30 days or 20 g·day-1 for 5-7 days (7). In this study the
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pre-workout beta-alanine and creatine dose was 2g and <2g respectively, which may not be
great enough to increase the buffering capacity and PCr stores even if taken for at least 4
weeks. Future research should look at the long-term effects of this pre-workout supplement
on anaerobic cycle ergometer performance.
In conclusion, the pre-workout supplement examined in this study did not elicit ergogenic
effects on anaerobic power (MP and PP) or power maintenance (%decline) following multiple
Wingate tests. Further testing is warranted to determine if this pre-workout supplement will
produce benefits in highly trained anaerobic athletes at relative doses of approximately
6mg·kg-1 or if long-term supplementation (>4 weeks) would elicit ergogenic effects on
anaerobic power.
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